Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Features of Human CD3+CD20+ T Cells.
Severe Cognitive Impairment Associated With Intrathecal Antibodies to the NR1 Subunit of the N-Methyl-D-Aspartate Receptor in a Patient With Multiple Sclerosis.
Stepchild or Prodigy? Neuroprotection in Multiple Sclerosis (MS) Research.
Novartis provides update on fingolimod Phase III trial in primary progressive MS (PPMS)
Fatigue in patients with multiple sclerosis: is it related to pro- and anti-inflammatory cytokines?
Benign Multiple Sclerosis is Associated with Reduced Thinning of the Retinal Nerve Fiber and Ganglion Cell Layers in Non-Optic-Neuritis Eyes.
Multiple sclerosis: getting personal with induced pluripotent stem cells.
Magnetic resonance imaging of the cervical spinal cord in multiple sclerosis at 7T.
Screening for neurotropic viruses in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases.
Macrophage-Targeted Therapy: CD64-Based Immunotoxins for Treatment of Chronic Inflammatory Diseases.
Quantitative magnetic resonance imaging of cortical multiple sclerosis pathology.
Developmentally regulated GTP-binding protein 2 ameliorates EAE by suppressing the development of TH17 cells.
Vitamin D, steroid hormones, and autoimmunity.
Does antiretroviral therapy for HIV reduce the risk of developing multiple sclerosis?
Seminal vesicle fluid ameliorates experimental autoimmune encephalomyelitis by increasing FoxP3(+) regulatory T-cell numbers.
Quality of life and cognitive functions in early onset multiple sclerosis.
Prevalence and risk factors for depression in women with multiple sclerosis: a study from Iran.
Novel molecular insights into classical and alternative activation states of microglia as revealed by SILAC-based proteomics.
Reduced cortical microvascular oxygenation in multiple sclerosis: a blinded, case-controlled study using a novel quantitative near-infrared spectroscopy method.
European multiple sclerosis risk variants in the south Asian population.
Progressive MS: from pathophysiology to drug discovery.
Nitrous Oxide Abuse and Vitamin B12 Action in a 20-Year-Old Woman: A Case Report.
Progesterone Enhanced Remyelination in the Mouse Corpus Callosum after Cuprizone Induced Demyelination.
Longitudinal associations between brain structural changes and fatigue in early MS.
Cross-validation of oxygen uptake prediction during walking in ambulatory persons with multiple sclerosis.
Pages
« first
‹ previous
…
535
536
537
538
539
540
541
542
543
…
next ›
last »